APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-animal Type Hard Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Research

Non-animal Type Hard Capsules Industry Research Report 2026

22 December 2025134 pages

Choose your research edition.

Industry ResearchNon-animal Type Hard Capsules Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-animal Type Hard Capsules Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Non-animal Type Hard Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-animal Type Hard Capsules Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-animal Type Hard Capsules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Non-animal Type Hard Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Non-animal Type Hard Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Non-animal Type Hard Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Non-animal Type Hard Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Non-animal Type Hard Capsules include Lonza, Hunan Er-Kang Pharmaceutical Co., Ltd, Sunil Healthcare, Roxlor, Qualicaps (Mitsubishi Chemical), Procaps S.A, Pharco, Patheon (Banner Pharmacaps) and Medicaps, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Non-animal Type Hard Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Non-animal Type Hard Capsules Market by Company

Lonza

Hunan Er-Kang Pharmaceutical Co., Ltd

Sunil Healthcare

Roxlor

Qualicaps (Mitsubishi Chemical)

Procaps S.A

Pharco

Patheon (Banner Pharmacaps)

Medicaps

Jedco International Pharmaceutical

JC Biological Technology

Catalent

CapsCanada

Bahrain Pharma

Arab-Caps

Aenova

ACPL

ACG Associated Capsules

Non-animal Type Hard Capsules Segment by Type

Type I

00E

0E

Non-animal Type Hard Capsules Segment by Application

Pharmaceutical

Nutraceutical

Cosmetics

Non-animal Type Hard Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Type Hard Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-animal Type Hard Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Type Hard Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Non-animal Type Hard Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Non-animal Type Hard Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Non-animal Type Hard Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non-animal Type Hard Capsules Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Non-animal Type Hard Capsules Sales (k units) of Manufacturers (2021-2026) Table 7. Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2021-2026) Table 8. Global Non-animal Type Hard Capsules Revenue of Manufacturers (2021-2026) Table 9. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Non-animal Type Hard Capsules Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Non-animal Type Hard Capsules Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Non-animal Type Hard Capsules, Product Type & Application Table 14. Global Non-animal Type Hard Capsules Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Non-animal Type Hard Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Lonza Company Information Table 19. Lonza Business Overview Table 20. Lonza Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Lonza Non-animal Type Hard Capsules Product Portfolio Table 22. Lonza Recent Developments Table 23. Hunan Er-Kang Pharmaceutical Co., Ltd Company Information Table 24. Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview Table 25. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio Table 27. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments Table 28. Sunil Healthcare Company Information Table 29. Sunil Healthcare Business Overview Table 30. Sunil Healthcare Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio Table 32. Sunil Healthcare Recent Developments Table 33. Roxlor Company Information Table 34. Roxlor Business Overview Table 35. Roxlor Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Roxlor Non-animal Type Hard Capsules Product Portfolio Table 37. Roxlor Recent Developments Table 38. Qualicaps (Mitsubishi Chemical) Company Information Table 39. Qualicaps (Mitsubishi Chemical) Business Overview Table 40. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio Table 42. Qualicaps (Mitsubishi Chemical) Recent Developments Table 43. Procaps S.A Company Information Table 44. Procaps S.A Business Overview Table 45. Procaps S.A Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Procaps S.A Non-animal Type Hard Capsules Product Portfolio Table 47. Procaps S.A Recent Developments Table 48. Pharco Company Information Table 49. Pharco Business Overview Table 50. Pharco Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Pharco Non-animal Type Hard Capsules Product Portfolio Table 52. Pharco Recent Developments Table 53. Patheon (Banner Pharmacaps) Company Information Table 54. Patheon (Banner Pharmacaps) Business Overview Table 55. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio Table 57. Patheon (Banner Pharmacaps) Recent Developments Table 58. Medicaps Company Information Table 59. Medicaps Business Overview Table 60. Medicaps Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Medicaps Non-animal Type Hard Capsules Product Portfolio Table 62. Medicaps Recent Developments Table 63. Jedco International Pharmaceutical Company Information Table 64. Jedco International Pharmaceutical Business Overview Table 65. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio Table 67. Jedco International Pharmaceutical Recent Developments Table 68. JC Biological Technology Company Information Table 69. JC Biological Technology Business Overview Table 70. JC Biological Technology Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. JC Biological Technology Non-animal Type Hard Capsules Product Portfolio Table 72. JC Biological Technology Recent Developments Table 73. Catalent Company Information Table 74. Catalent Business Overview Table 75. Catalent Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Catalent Non-animal Type Hard Capsules Product Portfolio Table 77. Catalent Recent Developments Table 78. CapsCanada Company Information Table 79. CapsCanada Business Overview Table 80. CapsCanada Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. CapsCanada Non-animal Type Hard Capsules Product Portfolio Table 82. CapsCanada Recent Developments Table 83. Bahrain Pharma Company Information Table 84. Bahrain Pharma Business Overview Table 85. Bahrain Pharma Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio Table 87. Bahrain Pharma Recent Developments Table 88. Arab-Caps Company Information Table 89. Arab-Caps Business Overview Table 90. Arab-Caps Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Arab-Caps Non-animal Type Hard Capsules Product Portfolio Table 92. Arab-Caps Recent Developments Table 93. Aenova Company Information Table 94. Aenova Business Overview Table 95. Aenova Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Aenova Non-animal Type Hard Capsules Product Portfolio Table 97. Aenova Recent Developments Table 98. ACPL Company Information Table 99. ACPL Business Overview Table 100. ACPL Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. ACPL Non-animal Type Hard Capsules Product Portfolio Table 102. ACPL Recent Developments Table 103. ACG Associated Capsules Company Information Table 104. ACG Associated Capsules Business Overview Table 105. ACG Associated Capsules Non-animal Type Hard Capsules Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio Table 107. ACG Associated Capsules Recent Developments Table 108. Global Non-animal Type Hard Capsules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Non-animal Type Hard Capsules Sales by Region (2021-2026) & (k units) Table 110. Global Non-animal Type Hard Capsules Sales Market Share by Region (2021-2026) Table 111. Global Non-animal Type Hard Capsules Sales by Region (2027-2032) & (k units) Table 112. Global Non-animal Type Hard Capsules Sales Market Share by Region (2027-2032) Table 113. Global Non-animal Type Hard Capsules Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2021-2026) Table 115. Global Non-animal Type Hard Capsules Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2027-2032) Table 117. North America Non-animal Type Hard Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 119. North America Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 120. North America Non-animal Type Hard Capsules Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Non-animal Type Hard Capsules Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Non-animal Type Hard Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 124. Europe Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 125. Europe Non-animal Type Hard Capsules Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Non-animal Type Hard Capsules Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Non-animal Type Hard Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Non-animal Type Hard Capsules Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Non-animal Type Hard Capsules Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Non-animal Type Hard Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 134. South America Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 135. South America Non-animal Type Hard Capsules Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Non-animal Type Hard Capsules Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Non-animal Type Hard Capsules Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Non-animal Type Hard Capsules Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Non-animal Type Hard Capsules Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Non-animal Type Hard Capsules Sales by Type (2021-2026) & (k units) Table 143. Global Non-animal Type Hard Capsules Sales by Type (2027-2032) & (k units) Table 144. Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2026) Table 145. Global Non-animal Type Hard Capsules Sales Market Share by Type (2027-2032) Table 146. Global Non-animal Type Hard Capsules Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Non-animal Type Hard Capsules Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2026) Table 149. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2027-2032) Table 150. Global Non-animal Type Hard Capsules Price by Type (2021-2026) & (US$/unit) Table 151. Global Non-animal Type Hard Capsules Price by Type (2027-2032) & (US$/unit) Table 152. Global Non-animal Type Hard Capsules Sales by Application (2021-2026) & (k units) Table 153. Global Non-animal Type Hard Capsules Sales by Application (2027-2032) & (k units) Table 154. Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2026) Table 155. Global Non-animal Type Hard Capsules Sales Market Share by Application (2027-2032) Table 156. Global Non-animal Type Hard Capsules Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Non-animal Type Hard Capsules Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2026) Table 159. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2027-2032) Table 160. Global Non-animal Type Hard Capsules Price by Application (2021-2026) & (US$/unit) Table 161. Global Non-animal Type Hard Capsules Price by Application (2027-2032) & (US$/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Non-animal Type Hard Capsules Distributors List Table 165. Non-animal Type Hard Capsules Customers List Table 166. Non-animal Type Hard Capsules Industry Trends Table 167. Non-animal Type Hard Capsules Industry Drivers Table 168. Non-animal Type Hard Capsules Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Non-animal Type Hard Capsules Product Image Figure 5. Global Non-animal Type Hard Capsules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Non-animal Type Hard Capsules Market Size (2021-2032) & (US$ Million) Figure 7. Global Non-animal Type Hard Capsules Sales (2021-2032) & (k units) Figure 8. Global Non-animal Type Hard Capsules Average Price (US$/unit) & (2021-2032) Figure 9. Type I Product Image Figure 10. 00E Product Image Figure 11. 0E Product Image Figure 12. Pharmaceutical Product Image Figure 13. Nutraceutical Product Image Figure 14. Cosmetics Product Image Figure 15. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Non-animal Type Hard Capsules Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Non-animal Type Hard Capsules Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Non-animal Type Hard Capsules Sales by Region in 2025 Figure 21. Global Non-animal Type Hard Capsules Revenue by Region in 2025 Figure 22. North America Non-animal Type Hard Capsules Market Size by Country in 2025 Figure 23. North America Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 24. North America Non-animal Type Hard Capsules Revenue Market Share by Country (2021-2032) Figure 25. United States Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Non-animal Type Hard Capsules Market Size by Country in 2025 Figure 29. Europe Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 30. Europe Non-animal Type Hard Capsules Revenue Market Share by Country (2021-2032) Figure 31. Germany Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Non-animal Type Hard Capsules Market Size by Country in 2025 Figure 42. Asia Pacific Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Non-animal Type Hard Capsules Revenue Market Share by Country (2021-2032) Figure 44. China Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Non-animal Type Hard Capsules Market Size by Country in 2025 Figure 53. South America Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 54. South America Non-animal Type Hard Capsules Revenue Market Share by Country (2021-2032) Figure 55. Brazil Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Non-animal Type Hard Capsules Market Size by Country in 2025 Figure 60. Middle East and Africa Non-animal Type Hard Capsules Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Non-animal Type Hard Capsules Revenue Market Share by Country (2021-2032) Figure 62. Egypt Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Non-animal Type Hard Capsules Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2032) Figure 68. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2032) Figure 69. Global Non-animal Type Hard Capsules Price (US$/unit) by Type (2021-2032) Figure 70. Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2032) Figure 71. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2032) Figure 72. Global Non-animal Type Hard Capsules Price (US$/unit) by Application (2021-2032) Figure 73. Non-animal Type Hard Capsules Value Chain Figure 74. Non-animal Type Hard Capsules Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Non-animal Type Hard Capsules Industry Opportunities and Challenges

Scope & coverage.

Types
  • Type I
  • 00E
  • 0E
Applications
  • Pharmaceutical
  • Nutraceutical
  • Cosmetics
Companies covered
  • Lonza
  • Hunan Er-Kang Pharmaceutical Co., Ltd
  • Sunil Healthcare
  • Roxlor
  • Qualicaps (Mitsubishi Chemical)
  • Procaps S.A
  • Pharco
  • Patheon (Banner Pharmacaps)
  • Medicaps
  • Jedco International Pharmaceutical
  • JC Biological Technology
  • Catalent
  • CapsCanada
  • Bahrain Pharma
  • Arab-Caps
  • Aenova
  • ACPL
  • ACG Associated Capsules

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Non-animal Type Hard Capsules Market Size (2021-2032)
  4. 2.2.2 Global Non-animal Type Hard Capsules Sales (2021-2032)
  5. 2.2.3 Global Non-animal Type Hard Capsules Market Average Price (2021-2032)
  6. 2.3 Non-animal Type Hard Capsules by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Type I
  9. 2.3.3 00E
  10. 2.3.4 0E
  11. 2.4 Non-animal Type Hard Capsules by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Pharmaceutical
  14. 2.4.3 Nutraceutical
  15. 2.4.4 Cosmetics
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Non-animal Type Hard Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Non-animal Type Hard Capsules Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Non-animal Type Hard Capsules Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Non-animal Type Hard Capsules Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Non-animal Type Hard Capsules Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Non-animal Type Hard Capsules, Product Type & Application
  8. 3.8 Global Manufacturers of Non-animal Type Hard Capsules, Established Date
  9. 3.9 Global Non-animal Type Hard Capsules Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Lonza
  2. 4.1.1 Lonza Company Information
  3. 4.1.2 Lonza Business Overview
  4. 4.1.3 Lonza Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Lonza Non-animal Type Hard Capsules Product Portfolio
  6. 4.1.5 Lonza Recent Developments
  7. 4.2 Hunan Er-Kang Pharmaceutical Co., Ltd
  8. 4.2.1 Hunan Er-Kang Pharmaceutical Co., Ltd Company Information
  9. 4.2.2 Hunan Er-Kang Pharmaceutical Co., Ltd Business Overview
  10. 4.2.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio
  12. 4.2.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments
  13. 4.3 Sunil Healthcare
  14. 4.3.1 Sunil Healthcare Company Information
  15. 4.3.2 Sunil Healthcare Business Overview
  16. 4.3.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio
  18. 4.3.5 Sunil Healthcare Recent Developments
  19. 4.4 Roxlor
  20. 4.4.1 Roxlor Company Information
  21. 4.4.2 Roxlor Business Overview
  22. 4.4.3 Roxlor Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Roxlor Non-animal Type Hard Capsules Product Portfolio
  24. 4.4.5 Roxlor Recent Developments
  25. 4.5 Qualicaps (Mitsubishi Chemical)
  26. 4.5.1 Qualicaps (Mitsubishi Chemical) Company Information
  27. 4.5.2 Qualicaps (Mitsubishi Chemical) Business Overview
  28. 4.5.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio
  30. 4.5.5 Qualicaps (Mitsubishi Chemical) Recent Developments
  31. 4.6 Procaps S.A
  32. 4.6.1 Procaps S.A Company Information
  33. 4.6.2 Procaps S.A Business Overview
  34. 4.6.3 Procaps S.A Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Procaps S.A Non-animal Type Hard Capsules Product Portfolio
  36. 4.6.5 Procaps S.A Recent Developments
  37. 4.7 Pharco
  38. 4.7.1 Pharco Company Information
  39. 4.7.2 Pharco Business Overview
  40. 4.7.3 Pharco Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pharco Non-animal Type Hard Capsules Product Portfolio
  42. 4.7.5 Pharco Recent Developments
  43. 4.8 Patheon (Banner Pharmacaps)
  44. 4.8.1 Patheon (Banner Pharmacaps) Company Information
  45. 4.8.2 Patheon (Banner Pharmacaps) Business Overview
  46. 4.8.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio
  48. 4.8.5 Patheon (Banner Pharmacaps) Recent Developments
  49. 4.9 Medicaps
  50. 4.9.1 Medicaps Company Information
  51. 4.9.2 Medicaps Business Overview
  52. 4.9.3 Medicaps Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Medicaps Non-animal Type Hard Capsules Product Portfolio
  54. 4.9.5 Medicaps Recent Developments
  55. 4.10 Jedco International Pharmaceutical
  56. 4.10.1 Jedco International Pharmaceutical Company Information
  57. 4.10.2 Jedco International Pharmaceutical Business Overview
  58. 4.10.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio
  60. 4.10.5 Jedco International Pharmaceutical Recent Developments
  61. 4.11 JC Biological Technology
  62. 4.11.1 JC Biological Technology Company Information
  63. 4.11.2 JC Biological Technology Business Overview
  64. 4.11.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 JC Biological Technology Non-animal Type Hard Capsules Product Portfolio
  66. 4.11.5 JC Biological Technology Recent Developments
  67. 4.12 Catalent
  68. 4.12.1 Catalent Company Information
  69. 4.12.2 Catalent Business Overview
  70. 4.12.3 Catalent Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Catalent Non-animal Type Hard Capsules Product Portfolio
  72. 4.12.5 Catalent Recent Developments
  73. 4.13 CapsCanada
  74. 4.13.1 CapsCanada Company Information
  75. 4.13.2 CapsCanada Business Overview
  76. 4.13.3 CapsCanada Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CapsCanada Non-animal Type Hard Capsules Product Portfolio
  78. 4.13.5 CapsCanada Recent Developments
  79. 4.14 Bahrain Pharma
  80. 4.14.1 Bahrain Pharma Company Information
  81. 4.14.2 Bahrain Pharma Business Overview
  82. 4.14.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio
  84. 4.14.5 Bahrain Pharma Recent Developments
  85. 4.15 Arab-Caps
  86. 4.15.1 Arab-Caps Company Information
  87. 4.15.2 Arab-Caps Business Overview
  88. 4.15.3 Arab-Caps Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Arab-Caps Non-animal Type Hard Capsules Product Portfolio
  90. 4.15.5 Arab-Caps Recent Developments
  91. 4.16 Aenova
  92. 4.16.1 Aenova Company Information
  93. 4.16.2 Aenova Business Overview
  94. 4.16.3 Aenova Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Aenova Non-animal Type Hard Capsules Product Portfolio
  96. 4.16.5 Aenova Recent Developments
  97. 4.17 ACPL
  98. 4.17.1 ACPL Company Information
  99. 4.17.2 ACPL Business Overview
  100. 4.17.3 ACPL Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 ACPL Non-animal Type Hard Capsules Product Portfolio
  102. 4.17.5 ACPL Recent Developments
  103. 4.18 ACG Associated Capsules
  104. 4.18.1 ACG Associated Capsules Company Information
  105. 4.18.2 ACG Associated Capsules Business Overview
  106. 4.18.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio
  108. 4.18.5 ACG Associated Capsules Recent Developments
5 Global Non-animal Type Hard Capsules Market Scenario by Region
  1. 5.1 Global Non-animal Type Hard Capsules Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Non-animal Type Hard Capsules Sales by Region: 2021-2032
  3. 5.2.1 Global Non-animal Type Hard Capsules Sales by Region: 2021-2026
  4. 5.2.2 Global Non-animal Type Hard Capsules Sales by Region: 2027-2032
  5. 5.3 Global Non-animal Type Hard Capsules Revenue by Region: 2021-2032
  6. 5.3.1 Global Non-animal Type Hard Capsules Revenue by Region: 2021-2026
  7. 5.3.2 Global Non-animal Type Hard Capsules Revenue by Region: 2027-2032
  8. 5.4 North America Non-animal Type Hard Capsules Market Facts & Figures by Country
  9. 5.4.1 North America Non-animal Type Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Non-animal Type Hard Capsules Sales by Country (2021-2032)
  11. 5.4.3 North America Non-animal Type Hard Capsules Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Non-animal Type Hard Capsules Market Facts & Figures by Country
  16. 5.5.1 Europe Non-animal Type Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Non-animal Type Hard Capsules Sales by Country (2021-2032)
  18. 5.5.3 Europe Non-animal Type Hard Capsules Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Non-animal Type Hard Capsules Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Non-animal Type Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Non-animal Type Hard Capsules Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Non-animal Type Hard Capsules Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Non-animal Type Hard Capsules Market Facts & Figures by Country
  41. 5.7.1 South America Non-animal Type Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Non-animal Type Hard Capsules Sales by Country (2021-2032)
  43. 5.7.3 South America Non-animal Type Hard Capsules Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Non-animal Type Hard Capsules Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Non-animal Type Hard Capsules Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Non-animal Type Hard Capsules Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Non-animal Type Hard Capsules Sales by Type (2021-2032)
  2. 6.1.1 Global Non-animal Type Hard Capsules Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Non-animal Type Hard Capsules Sales Market Share by Type (2021-2032)
  4. 6.2 Global Non-animal Type Hard Capsules Revenue by Type (2021-2032)
  5. 6.2.1 Global Non-animal Type Hard Capsules Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Non-animal Type Hard Capsules Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Non-animal Type Hard Capsules Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Non-animal Type Hard Capsules Sales by Application (2021-2032)
  2. 7.1.1 Global Non-animal Type Hard Capsules Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Non-animal Type Hard Capsules Sales Market Share by Application (2021-2032)
  4. 7.2 Global Non-animal Type Hard Capsules Revenue by Application (2021-2032)
  5. 7.2.1 Global Non-animal Type Hard Capsules Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Non-animal Type Hard Capsules Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Non-animal Type Hard Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Non-animal Type Hard Capsules Value Chain Analysis
  2. 8.1.1 Non-animal Type Hard Capsules Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Non-animal Type Hard Capsules Production Mode & Process
  5. 8.2 Non-animal Type Hard Capsules Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Non-animal Type Hard Capsules Distributors
  8. 8.2.3 Non-animal Type Hard Capsules Customers
9 Global Non-animal Type Hard Capsules Analyzing Market Dynamics
  1. 9.1 Non-animal Type Hard Capsules Industry Trends
  2. 9.2 Non-animal Type Hard Capsules Industry Drivers
  3. 9.3 Non-animal Type Hard Capsules Industry Opportunities and Challenges
  4. 9.4 Non-animal Type Hard Capsules Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst